GILEAD SCIENCES, INC. Accrued Liabilities, Current
GILEAD SCIENCES, INC. (GILD) had Accrued Liabilities, Current of $3.87 billion as of 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-11-02
- 2022-09-30: Accrued Liabilities, Current $3.87B.
- 2022-06-30: Accrued Liabilities, Current $4.12B.
- 2022-03-31: Accrued Liabilities, Current $3.50B.
- 2021-12-31: Accrued Liabilities, Current $6.14B.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2022-09-30 | $3.87B 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $4.12B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $3.50B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $6.14B 10-Q · filed 2022-11-02 | |
| 2021-09-30 | $3.78B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $4.05B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $3.51B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $4.34B 10-K · filed 2022-02-23 | |
| 2020-09-30 | $4.14B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $3.70B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.83B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $3.07B 10-K · filed 2021-02-25 | |
| 2019-09-30 | $2.79B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.76B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $2.35B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $3.14B 10-K · filed 2020-02-25 | |
| 2018-09-30 | $2.33B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $2.61B 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $2.41B 10-Q · filed 2018-05-09 | |
| 2018-01-01 | $3.25B 10-K · filed 2019-02-26 | |
| 2017-12-31 | $3.37B 10-K · filed 2019-02-26 | |
| 2017-09-30 | $2.48B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $2.99B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $2.63B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $2.99B 10-K · filed 2018-02-27 | $2.79B 10-K · filed 2017-02-27 |
| 2016-09-30 | $3.48B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $2.83B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $2.92B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $3.17B 10-K · filed 2017-02-27 | |
| 2015-09-30 | $2.72B 10-Q · filed 2015-11-04 | |
| 2014-12-31 | $1.87B 10-K · filed 2016-02-24 | |
| 2012-06-30 | $624.34M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $593.06M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $471.13M 10-Q · filed 2012-08-01 | $502.56M 10-K · filed 2012-02-23 |
| 2011-09-30 | $495.31M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $618.22M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $566.57M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $437.89M 10-K · filed 2012-02-23 | |
| 2010-09-30 | $443.76M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $373.73M 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $388.90M 10-Q · filed 2010-05-10 | |
| 2009-12-31 | $384.01M 10-K · filed 2011-02-28 | |
| 2009-09-30 | $395.66M 10-Q · filed 2009-11-05 | |
| 2009-06-30 | $291.31M 10-Q · filed 2009-08-05 | |
| 2008-12-31 | $245.66M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |